Headaches in Young People and adults

26th October 2012 by Louise Hudman

This is a monster of a guideline from NICE, which is only aimed at people over the age of 12. This email contains the summary, but if you want to read more, then use the link at the bottom.

My main feeling about this guideline, having trawled though the 360 pages of evidence, is that it is more a summary of what we currently know, than a guideline. They exclude commonly used treatments like amitriptyline and pizotifen from the guideline, not because there is evidence that they are ineffective, but because the studies just haven’t been done yet. A lot of the evidence that is available, is of poor quality and is often contradictory.

From my personal point of view, this guideline will not be changing my practice much.


Join to view the rest of this content, as well as access all the benefits of joining NASGP.



Already a member? Login to view this content.


"The quality and contents of the magazine are superb. It's wonderful that GP locums now have a voice and are seen as a vital part of the medical workforce."

Dr Irene Bainbridge

See the full list of features within our NASGP membership plans